Autolus Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Renata Kellnerova(5.5%),PPF GROUP N.V.(5.5%)等
Autolus Therapeutics | D:发行公告
Autolus Therapeutics | SC 13D:超过5%持股股东披露文件-BioNTech SE(12.5%)
Autolus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Autolus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(2.21%),Steven Boyd(2.21%)
Autolus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(6.82%),Deep Track Biotechnology Master Fund, Ltd.(6.82%)等
Autolus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Autolus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Tetragon Financial Group Limited(4.6%),Tetragon Financial Management L.P.(4.6%)等
Autolus Therapeutics | SC 13G:超过5%持股股东披露文件
Autolus Therapeutics | SC 13G:超过5%持股股东披露文件-Tetragon Financial Group Limited(5.5%),Tetragon Financial Management L.P.(5.5%)等
Autolus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Nantahala Capital Management, LLC(4.7%),Wilmot B. Harkey(4.7%)等
Autolus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-James N. Topper(2.2%),Patrick J. Heron(2.2%)等
Autolus Therapeutics | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(5.91%),Steven Boyd(5.91%)
Autolus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Autolus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(8.67%),Deep Track Biotechnology Master Fund, Ltd.(8.67%)等
Autolus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Capital World Investors(0.4%)
Autolus Therapeutics | SC 13G:超过5%持股股东披露文件-Deep Track Capital, LP(9.03%),Deep Track Biotechnology Master Fund, Ltd.(9.03%)等
Autolus Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-BXLS V – Autobahn L.P.(14.0%),Blackstone Life Sciences Associates V (CYM) L.L.C.(14.0%)等
Autolus Therapeutics | SC 13G:超过5%持股股东披露文件-Qatar Investment Authority(9.03%)
Autolus Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Renata Kellnerova(16.1%),PPF GROUP N.V.(16.1%)等
暂无数据